SCHEMBL4991763

SCHEMBL4991763

O=C(O)c1ccc(-c2nccc(-c3cc4n(n3)CCNC4=O)n2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 1/20 0.52
MAPKAPK2 P49137 3/20 0.40
PIM1 P11309 1/20 0.37
PIM2 Q9P1W9 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 2/20 0.36
PRNP P04156 1/20 0.36
POLB P06746 1/20 0.36
GAA P10253 1/20 0.36
ITGA2B P08514 1/20 0.36
CAMK2D Q13557 4/20 0.36
LOXL2 Q9Y4K0 1/20 0.36
MAP4K4 O95819 1/20 0.36
MAPK8 P45983 1/20 0.35
PIK3CG P48736 1/20 0.35
GSK3B P49841 1/20 0.35
CAMKK2 Q96RR4 1/20 0.35
ALDH1A1 P00352 1/20 0.34
JMJD6 Q6NYC1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4996859 0.99 CDC7 (0.51) CDC7MAPKAPK2PIM1PIM2MEN1
SCHEMBL4991418 0.90 CDC7 (0.49) CDC7MAPKAPK2PIM1PIM2MEN1
SCHEMBL4995882 0.90 CDC7 (0.49) CDC7MAPKAPK2PIM1PIM2MEN1
SCHEMBL4997344 0.90 CDC7 (0.51) CDC7MAPKAPK2PIM1PIM2MEN1
SCHEMBL4991016 0.88 CDC7 (0.54) CDC7MAPKAPK2PIM1PIM2MEN1
SCHEMBL4995841 0.88 CDC7 (0.54) CDC7MAPKAPK2PIM1PIM2MEN1
SCHEMBL4990601 0.88 CDC7 (0.56) CDC7PIM1PIM2MEN1KMT2A
SCHEMBL4997440 0.88 CDC7 (0.49) CDC7MAPKAPK2PIM1PIM2KDM4E
SCHEMBL4994895 0.87 CDC7 (0.56) CDC7PIM1PIM2MEN1KMT2A
SCHEMBL4993179 0.87 CDC7 (0.53) CDC7MAPKAPK2PIM1PIM2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS HANAU CATHLEEN E 2008-05-15 US disclosed
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS HANAU CATHLEEN E 2008-05-15 US disclosed
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS HANAU CATHLEEN E 2008-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS MKNK2, MAPKAPK2, MAP3K2 CDC7 487/4885MAPKAPK2 2/4885PIM1 539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.